BE838273A - IMMUNOLOGICAL CYTOTOXIC AGENTS - Google Patents

IMMUNOLOGICAL CYTOTOXIC AGENTS

Info

Publication number
BE838273A
BE838273A BE164096A BE164096A BE838273A BE 838273 A BE838273 A BE 838273A BE 164096 A BE164096 A BE 164096A BE 164096 A BE164096 A BE 164096A BE 838273 A BE838273 A BE 838273A
Authority
BE
Belgium
Prior art keywords
emi
immunological
cytotoxic agents
cytotoxic
agents
Prior art date
Application number
BE164096A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB4695/75A external-priority patent/GB1496011A/en
Application filed filed Critical
Publication of BE838273A publication Critical patent/BE838273A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicinal Preparation (AREA)

Description

       

   <EMI ID=1.1>  

  
 <EMI ID=2.1> 

  

 <EMI ID=3.1> 


  
 <EMI ID=4.1>   <EMI ID=5.1>  

  
 <EMI ID=6.1> 

  

 <EMI ID=7.1> 


  
 <EMI ID=8.1> 

  

 <EMI ID=9.1> 


  
 <EMI ID=10.1> 

  
 <EMI ID=11.1> 

  
 <EMI ID=12.1>   <EMI ID=13.1> 
 <EMI ID=14.1> 
-ou
 <EMI ID=15.1> 
 <EMI ID=16.1> 

  

 <EMI ID=17.1> 


  
 <EMI ID=18.1>  

  

 <EMI ID=19.1> 


  
 <EMI ID=20.1> 

  

 <EMI ID=21.1> 


  
 <EMI ID=22.1> 

  
cptb 

  

 <EMI ID=23.1> 


  
 <EMI ID=24.1> 

  

 <EMI ID=25.1> 


  
 <EMI ID=26.1> 

  
'  
 <EMI ID=27.1> 
 <EMI ID=28.1> 

CPCQ)

  

 <EMI ID=29.1> 


  
 <EMI ID=30.1> 

  

 <EMI ID=31.1> 


  
 <EMI ID=32.1>  

  
 <EMI ID=33.1>   <EMI ID=34.1>   <EMI ID=35.1> 

  

 <EMI ID=36.1> 


  
 <EMI ID=37.1>  

  

 <EMI ID=38.1> 


  
 <EMI ID=39.1>  

  
 <EMI ID=40.1> 

  

 <EMI ID=41.1> 


  
 <EMI ID=42.1>   <EMI ID=43.1> 

  

 <EMI ID=44.1> 


  
 <EMI ID=45.1>   <EMI ID=46.1> 

  

 <EMI ID=47.1> 
 

  

 <EMI ID=48.1> 
 

  
 <EMI ID=49.1> 

  

 <EMI ID=50.1> 


  
 <EMI ID=51.1>  

  
 <EMI ID=52.1> 

  

 <EMI ID=53.1> 
 

  

 <EMI ID=54.1> 


  
 <EMI ID=55.1> 

  

 <EMI ID=56.1> 


  
 <EMI ID=57.1> 

  
 <EMI ID=58.1> 
 <EMI ID=59.1> 
  <EMI ID=60.1> 

  

 <EMI ID=61.1> 


  
Dt

  
 <EMI ID=62.1>  

  
 <EMI ID=63.1> 

  

 <EMI ID=64.1> 

ÉLT

  
 <EMI ID=65.1> 

  

 <EMI ID=66.1> 


  
et

  
 <EMI ID=67.1>   <EMI ID=68.1>   <EMI ID=69.1> 

  

 <EMI ID=70.1> 


  
 <EMI ID=71.1>  

  
 <EMI ID=72.1> 

  

 <EMI ID=73.1> 


  
 <EMI ID=74.1> 
 <EMI ID=75.1> 
 <EMI ID=76.1>  

  
 <EMI ID=77.1> 
-qui suit" 
 <EMI ID=78.1> 
 <EMI ID=79.1> 

  

 <EMI ID=80.1> 


  
 <EMI ID=81.1>   <EMI ID=82.1> 

  

 <EMI ID=83.1> 


  
 <EMI ID=84.1> 

  
. 

  

 <EMI ID=85.1> 


  
 <EMI ID=86.1>   <EMI ID=87.1>  

  
 <EMI ID=88.1>  

  
 <EMI ID=89.1> 

  
 <EMI ID=90.1>  

  
 <EMI ID=91.1> 

  

 <EMI ID=92.1> 


  
 <EMI ID=93.1>   <EMI ID=94.1>   <EMI ID=95.1> 

  

 <EMI ID=96.1> 


  
 <EMI ID=97.1>  

  
 <EMI ID=98.1> 

  

 <EMI ID=99.1> 


  
 <EMI ID=100.1> 

  
 <EMI ID=101.1> 

  
 <EMI ID=102.1>   <EMI ID=103.1>  

  
 <EMI ID=104.1>  

  
 <EMI ID=105.1>   <EMI ID=106.1>  

  
E&#65533;KFf&#65533; 1&#65533;

  
 <EMI ID=107.1> 

  
suit ) 
 <EMI ID=108.1> 
  <EMI ID=109.1> 

  

 <EMI ID=110.1> 


  
 <EMI ID=111.1> 

  

 <EMI ID=112.1> 
 

  
 <EMI ID=113.1> 

  
VB&#65533;te ; 

  

 <EMI ID=114.1> 


  
 <EMI ID=115.1> 

  

 <EMI ID=116.1> 


  
 <EMI ID=117.1>   <EMI ID=118.1> 

  

 <EMI ID=119.1> 


  
 <EMI ID=120.1> 

  

 <EMI ID=121.1> 


  
 <EMI ID=122.1> 



   <EMI ID = 1.1>

  
 <EMI ID = 2.1>

  

 <EMI ID = 3.1>


  
 <EMI ID = 4.1> <EMI ID = 5.1>

  
 <EMI ID = 6.1>

  

 <EMI ID = 7.1>


  
 <EMI ID = 8.1>

  

 <EMI ID = 9.1>


  
 <EMI ID = 10.1>

  
 <EMI ID = 11.1>

  
 <EMI ID = 12.1> <EMI ID = 13.1>
 <EMI ID = 14.1>
-or
 <EMI ID = 15.1>
 <EMI ID = 16.1>

  

 <EMI ID = 17.1>


  
 <EMI ID = 18.1>

  

 <EMI ID = 19.1>


  
 <EMI ID = 20.1>

  

 <EMI ID = 21.1>


  
 <EMI ID = 22.1>

  
cptb

  

 <EMI ID = 23.1>


  
 <EMI ID = 24.1>

  

 <EMI ID = 25.1>


  
 <EMI ID = 26.1>

  
'
 <EMI ID = 27.1>
 <EMI ID = 28.1>

CPCQ)

  

 <EMI ID = 29.1>


  
 <EMI ID = 30.1>

  

 <EMI ID = 31.1>


  
 <EMI ID = 32.1>

  
 <EMI ID = 33.1> <EMI ID = 34.1> <EMI ID = 35.1>

  

 <EMI ID = 36.1>


  
 <EMI ID = 37.1>

  

 <EMI ID = 38.1>


  
 <EMI ID = 39.1>

  
 <EMI ID = 40.1>

  

 <EMI ID = 41.1>


  
 <EMI ID = 42.1> <EMI ID = 43.1>

  

 <EMI ID = 44.1>


  
 <EMI ID = 45.1> <EMI ID = 46.1>

  

 <EMI ID = 47.1>
 

  

 <EMI ID = 48.1>
 

  
 <EMI ID = 49.1>

  

 <EMI ID = 50.1>


  
 <EMI ID = 51.1>

  
 <EMI ID = 52.1>

  

 <EMI ID = 53.1>
 

  

 <EMI ID = 54.1>


  
 <EMI ID = 55.1>

  

 <EMI ID = 56.1>


  
 <EMI ID = 57.1>

  
 <EMI ID = 58.1>
 <EMI ID = 59.1>
  <EMI ID = 60.1>

  

 <EMI ID = 61.1>


  
Dt

  
 <EMI ID = 62.1>

  
 <EMI ID = 63.1>

  

 <EMI ID = 64.1>

ELT

  
 <EMI ID = 65.1>

  

 <EMI ID = 66.1>


  
and

  
 <EMI ID = 67.1> <EMI ID = 68.1> <EMI ID = 69.1>

  

 <EMI ID = 70.1>


  
 <EMI ID = 71.1>

  
 <EMI ID = 72.1>

  

 <EMI ID = 73.1>


  
 <EMI ID = 74.1>
 <EMI ID = 75.1>
 <EMI ID = 76.1>

  
 <EMI ID = 77.1>
-following"
 <EMI ID = 78.1>
 <EMI ID = 79.1>

  

 <EMI ID = 80.1>


  
 <EMI ID = 81.1> <EMI ID = 82.1>

  

 <EMI ID = 83.1>


  
 <EMI ID = 84.1>

  
.

  

 <EMI ID = 85.1>


  
 <EMI ID = 86.1> <EMI ID = 87.1>

  
 <EMI ID = 88.1>

  
 <EMI ID = 89.1>

  
 <EMI ID = 90.1>

  
 <EMI ID = 91.1>

  

 <EMI ID = 92.1>


  
 <EMI ID = 93.1> <EMI ID = 94.1> <EMI ID = 95.1>

  

 <EMI ID = 96.1>


  
 <EMI ID = 97.1>

  
 <EMI ID = 98.1>

  

 <EMI ID = 99.1>


  
 <EMI ID = 100.1>

  
 <EMI ID = 101.1>

  
 <EMI ID = 102.1> <EMI ID = 103.1>

  
 <EMI ID = 104.1>

  
 <EMI ID = 105.1> <EMI ID = 106.1>

  
E &#65533; KFf &#65533; 1 &#65533;

  
 <EMI ID = 107.1>

  
follows)
 <EMI ID = 108.1>
  <EMI ID = 109.1>

  

 <EMI ID = 110.1>


  
 <EMI ID = 111.1>

  

 <EMI ID = 112.1>
 

  
 <EMI ID = 113.1>

  
VB &#65533;te;

  

 <EMI ID = 114.1>


  
 <EMI ID = 115.1>

  

 <EMI ID = 116.1>


  
 <EMI ID = 117.1> <EMI ID = 118.1>

  

 <EMI ID = 119.1>


  
 <EMI ID = 120.1>

  

 <EMI ID = 121.1>


  
 <EMI ID = 122.1>

Claims (1)

<EMI ID=123.1> <EMI ID=124.1> <EMI ID=125.1> <EMI ID=126.1> <EMI ID=127.1> <EMI ID=128.1> <EMI ID=129.1> <EMI ID=130.1> <EMI ID = 123.1> <EMI ID = 124.1> <EMI ID = 125.1> <EMI ID = 126.1> <EMI ID = 127.1> <EMI ID = 128.1> <EMI ID = 129.1> <EMI ID = 130.1> <EMI ID=131.1> <EMI ID = 131.1> <EMI ID=132.1> <EMI ID = 132.1> <EMI ID=133.1> <EMI ID=134.1> <EMI ID=135.1> <EMI ID=136.1> <EMI ID=137.1> <EMI ID = 133.1> <EMI ID = 134.1> <EMI ID = 135.1> <EMI ID = 136.1> <EMI ID = 137.1> <EMI ID=138.1> <EMI ID = 138.1> <EMI ID=139.1> <EMI ID = 139.1> <EMI ID=140.1> <EMI ID=141.1> <EMI ID=142.1> <EMI ID=143.1> <EMI ID=144.1> <EMI ID = 140.1> <EMI ID = 141.1> <EMI ID = 142.1> <EMI ID = 143.1> <EMI ID = 144.1> <EMI ID=145.1> <EMI ID = 145.1> <EMI ID=146.1> <EMI ID=147.1> <EMI ID=148.1> <EMI ID=149.1> <EMI ID=150.1> <EMI ID=151.1> <EMI ID=152.1> <EMI ID=153.1> <EMI ID=154.1> <EMI ID=155.1> <EMI ID=156.1> <EMI ID=157.1> <EMI ID = 146.1> <EMI ID = 147.1> <EMI ID = 148.1> <EMI ID = 149.1> <EMI ID = 150.1> <EMI ID = 151.1> <EMI ID = 152.1> <EMI ID = 153.1> <EMI ID = 154.1> <EMI ID = 155.1> <EMI ID = 156.1> <EMI ID = 157.1> libre dit CP. <EMI ID=158.1> free says CP. <EMI ID = 158.1> . <EMI ID=159.1> . <EMI ID = 159.1> <EMI ID=160.1> <EMI ID = 160.1> <EMI ID=161.1> <EMI ID=162.1> <EMI ID = 161.1> <EMI ID = 162.1>
BE164096A 1975-02-04 1976-02-04 IMMUNOLOGICAL CYTOTOXIC AGENTS BE838273A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4695/75A GB1496011A (en) 1974-11-22 1975-02-04 Defoaming composition

Publications (1)

Publication Number Publication Date
BE838273A true BE838273A (en) 1976-08-04

Family

ID=9782062

Family Applications (1)

Application Number Title Priority Date Filing Date
BE164096A BE838273A (en) 1975-02-04 1976-02-04 IMMUNOLOGICAL CYTOTOXIC AGENTS

Country Status (5)

Country Link
JP (1) JPS51126281A (en)
BE (1) BE838273A (en)
DK (1) DK43676A (en)
NL (1) NL7601132A (en)
SE (1) SE7601125L (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2586564A1 (en) * 1985-09-04 1987-03-06 Pierre Tran Ba Loc Immunosuppressant compounds and process for preparing them
EP0279862A4 (en) * 1986-08-28 1990-01-08 Teijin Ltd Cytocidal antibody complex and process for its preparation.

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57143326A (en) * 1981-03-03 1982-09-04 Teijin Ltd Polymer linked to cellular toxic substance and its preparation
DE3205847A1 (en) * 1981-05-08 1982-12-16 Farmitalia Carlo Erba S.p.A., 20159 Milano Daunorubicin-protein conjugates
JPS60172935A (en) * 1984-02-16 1985-09-06 Green Cross Corp:The Preparation of composite material of substance having carcinostatic action
JPS611622A (en) * 1984-06-14 1986-01-07 Teijin Ltd Cytotoxic complex and preparation thereof
JPS62228025A (en) * 1985-12-27 1987-10-06 Teijin Ltd Production of antibody complex
JPH0662438B1 (en) * 1986-08-28 1994-08-17 Teijin Ltd
US5149782A (en) * 1988-08-19 1992-09-22 Tanox Biosystems, Inc. Molecular conjugates containing cell membrane-blending agents
JP2626654B2 (en) * 1990-03-31 1997-07-02 科学技術振興事業団 Targeting high molecular weight pharmaceutical compounds and intermediates thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2586564A1 (en) * 1985-09-04 1987-03-06 Pierre Tran Ba Loc Immunosuppressant compounds and process for preparing them
EP0279862A4 (en) * 1986-08-28 1990-01-08 Teijin Ltd Cytocidal antibody complex and process for its preparation.

Also Published As

Publication number Publication date
DK43676A (en) 1976-08-05
NL7601132A (en) 1976-08-06
JPS51126281A (en) 1976-11-04
SE7601125L (en) 1976-08-05

Similar Documents

Publication Publication Date Title
IT7927250A0 (en) MAGNESIUM-BASED COMPOSITION FOR THE STORAGE OF HYDROGEN AND PROCEDURE FOR THE PREPARATION OF THIS COMPOSITION.
BE838273A (en) IMMUNOLOGICAL CYTOTOXIC AGENTS
IT8721140V0 (en) STRUCTURE OF CLOTHES HANGERS WITH VARIABLE CONFIGURATION WITH ACCESSORY HOLDERS, PARTICULARLY FOR THE EXPOSURE OF CLOTHING IN GENERAL.
DE3883132D1 (en) SYNCHRONOUS SEMICONDUCTOR STORAGE DEVICE.
FR2585736B3 (en) MOLLETON KNITTED ARTICLE AND LAMINATED COMPLEX MADE FROM SUCH AN ARTICLE.
BE884749A (en) CATALYTIC AMENDMENT
BE837986A (en) MORE HOOK
GB2020285B (en) Pharmacologically active 1,3-benzodioxine dervatives
BE877078A (en) STIRRIER.
BE840688A (en) VETON STEEL COMPOSITE BRIDGE
BE879341A (en) HENGELHAAK
BE840009Q (en) PROTECTIVE COLLAR
BE835850A (en) DENTAL PROSTHESIS
BE872701A (en) TRANSPORT DEVICE
BE840716A (en) IRRADIATION INSTALLATION
BE840497A (en) PERFECTED TENT
BE840633A (en) SWIVEL SEAT FOR DISABLED PERSONS
BE840127A (en) GYMNASTIK ELEMENTE
BE840979A (en) GOODS CARRIER
BE840249A (en) FONDERINGSPAAL
BE841028A (en) DISHWASHER DEVICE
BE840956A (en) PHOTO ELECTRICAL DETECTOR
BE838280A (en) MONOAZOIC AND DIAZOIC COLORANTS
BE840706A (en) PERFECTED BRUSH
FR2616661B1 (en) ORAL-BASED MUCOPOLYSACCHARIDE-BASED COMPOSITION